Stock Fundamentals

AI Research Report

Generate a comprehensive financial analysis report powered by AI

PLSE.US Logo

PLSE.US - Current Price

$14.57

Company Information

▼
Company Name
Pulse Biosciences Inc
Sector
Healthcare
Industry
Medical Instruments & Supplies
Exchange
NASDAQ
ISIN: US74587B1017
CIK: 0001625101
CUSIP: 74587B101
Currency: USD
Full Time Employees: 75
Phone: 510 906 4600
Website: https://www.pulsebiosciences.com
Fiscal Year End: December
IPO Date: May 18, 2016
Description:

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; CellFX nsPFA Percutaneous Electrode system for soft tissue ablation in surgical setting; CellFX nsPFA Cardiac Clamp designed for use in surgical treatment of atrial fibrillation (AF); CellFX nsPFA 360° Cardiac Catheter designed to provide a circumferential, or circular, ablation in a single treatment cycle; and The CellFX Consol, a tunable, software-enabled, and console-based platform designed to accommodate the clinical workflow preferred by physicians. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Miami, Florida.

Address:

601 Brickell Key Drive, Miami, FL, United States, 33131

Directors & Officers

▼
Name Title Year Born
Mr. Paul Arthur LaViolette President, CEO & Co-Chairman of the Board 1958
Mr. Darrin R. Uecker CTO & Director 1966
Mr. Kevin P. Danahy Chief Commercial Officer 1971
Mr. Jon Skinner Chief Financial Officer 1986
Mr. Edison Manuel Vice President of Operations NA
Mr. Steven T. Weber VP of Accounting, Principal Accounting Officer & Global Corporate Controller 1976
Mr. Kenneth B. Stratton Esq., J.D. General Counsel & Corporate Secretary 1969
Ms. Patty Perla Vice President of Human Resources NA
Mr. Mitchell E. Levinson Chief Strategy Officer 1960
Mr. David Danitz Senior Vice President of Engineering NA

Shares Statistics

▼
Shares Outstanding: 67.77M
Shares Float: 17.57M
% Insiders: 7,394.40%
% Institutions: 873.60%
Short % Float: 13.34%

Valuation Metrics

▼
Enterprise Value: $894.63M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

▼
Market Cap: $958.23M
EBITDA: $-77.85M
PEG Ratio: $0.00
Book Value: $1.37
Earnings/Share: $-1.14
Profit Margin: 0.00%
Operating Margin: -23,682.56%
ROA (TTM): -48.90%
ROE (TTM): -86.99%
Revenue (TTM): $86.00K
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Stock Price History

▼

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

▼

Revenue & Net Income

Operating Expenses

Balance Sheet Overview

Earnings Per Share (EPS)

Earnings History

▼
Date EPS Actual EPS Estimate Difference Surprise %
Sep 30, 2025 -0.29 -0.31 N/A 645.16%
Jun 30, 2025 -0.28 -0.26 N/A -769.23%
Mar 31, 2025 -0.25 N/A N/A N/A
Dec 31, 2024 -0.31 -0.24 N/A -3,016.67%
Sep 30, 2024 -0.21 -0.24 N/A 1,350.00%
Jun 30, 2024 -0.20 -0.20 N/A 45.00%
Mar 31, 2024 -0.18 -0.24 N/A 2,345.83%
Dec 31, 2023 -0.22 -0.24 N/A 970.83%
Sep 30, 2023 -0.19 -0.22 N/A 1,363.64%
Jun 30, 2023 -0.22 -0.22 N/A 0.00%
Mar 31, 2023 -0.26 -0.22 N/A -1,818.18%
Dec 31, 2022 -0.25 -0.24 N/A -416.67%
Sep 30, 2022 -0.49 -0.45 N/A -888.89%
Jun 30, 2022 -0.44 -0.40 N/A -1,000.00%
Mar 31, 2022 -0.58 -0.52 N/A -1,153.85%
Dec 31, 2021 -0.52 -0.51 N/A -196.08%
Sep 30, 2021 -0.48 -0.53 N/A 943.40%
Jun 30, 2021 -0.58 -0.69 N/A 1,594.20%
Mar 31, 2021 -0.71 -0.49 N/A -4,489.80%
Dec 31, 2020 -0.54 -0.45 N/A -2,000.00%
Sep 30, 2020 -0.51 -0.44 N/A -1,590.91%
Jun 30, 2020 -0.53 -0.50 N/A -600.00%
Mar 31, 2020 -0.57 -0.47 N/A -2,127.66%
Dec 31, 2019 -0.66 -0.61 N/A -819.67%
Sep 30, 2019 -0.57 -0.61 N/A 655.74%
Jun 30, 2019 -0.55 -0.51 N/A -784.31%
Mar 31, 2019 -0.49 -0.44 N/A -1,136.36%
Dec 31, 2018 -0.51 -0.51 N/A 0.00%
Sep 30, 2018 -0.64 N/A N/A N/A
Jun 30, 2018 -0.54 N/A N/A N/A
Mar 31, 2018 -0.51 N/A N/A N/A
Dec 31, 2017 -0.52 N/A N/A N/A
Sep 30, 2017 -0.52 N/A N/A N/A
Jun 30, 2017 -0.43 N/A N/A N/A
Mar 31, 2017 -0.23 N/A N/A N/A
Dec 31, 2016 -0.21 N/A N/A N/A
Sep 30, 2016 -0.21 N/A N/A N/A
Jun 30, 2016 -0.23 N/A N/A N/A

Balance Sheet (Yearly)

▼
Date Cash Total Debt Total Assets Total Liabilities Total Equity
2024-12-31 $118.04M $N/A $132.46M $17.60M $114.86M
2023-12-31 $44.37M $N/A $59.15M $14.79M $44.36M
2022-12-31 $61.14M $N/A $77.88M $80.13M $-2.25M
2021-12-31 $28.61M $N/A $54.25M $18.56M $35.69M
2020-12-31 $12.46M $N/A $41.29M $18.40M $22.89M
2019-12-31 $6.90M $N/A $41.92M $11.18M $30.74M
2018-12-31 $51.10M $N/A $70.64M $4.31M $66.33M
2017-12-31 $3.39M $N/A $49.82M $3.83M $46.00M
2016-12-31 $2.09M $N/A $26.31M $1.02M $25.30M
2015-12-31 $3.61M $N/A $14.33M $659.76K $13.67M
2014-12-31 $7.01M $N/A $17.90M $1.82M $16.07M

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Oct 02, 2025 N/A N/A N/A N/A N/A N/A
Sep 19, 2025 N/A N/A N/A N/A N/A N/A
Sep 18, 2025 N/A N/A N/A N/A N/A N/A
Sep 17, 2025 N/A N/A N/A N/A N/A N/A
Sep 15, 2025 N/A N/A N/A N/A N/A N/A
Sep 11, 2025 N/A N/A N/A N/A N/A N/A
Sep 10, 2025 N/A N/A N/A N/A N/A N/A
Jun 12, 2025 N/A N/A N/A N/A N/A N/A
Dec 13, 2024 N/A N/A N/A N/A N/A N/A
Dec 11, 2024 N/A N/A N/A N/A N/A N/A
Dec 11, 2024 N/A N/A N/A N/A N/A N/A

Watchlist

0

No stocks in watchlist